They might sell big, but are they worth your money?
Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 Affecting up to 100,000 people in the U.S. and up to 5.6 ...
The broader PROGRESS clinical development program continues to evaluate zilurgisertib in younger children with FOP. Enrollment has been completed in Cohort 2, which includes children aged 6 to under ...
Please provide your email address to receive an email when new articles are posted on . Nerandomilast is the first oral preferential phosphodiesterase 4B inhibitor approved for progressive pulmonary ...
The FDA approved tavapadon (Juvmo) tablets for the treatment of adults with Parkinson disease (PD). The company described the ...
Bactrim (sulfamethoxazole/trimethoprim) is a prescription oral tablet used to treat and prevent certain types of bacterial infections. Your dosage will depend on the ...
Formula combines L-leucine, L-valine, L-isoleucine, L-lysine HCl, L-phenylalanine, L-threonine, L-methionine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results